10
Jul
2024

Zhejiang Hisun Pharmaceuticals Co Ltd

Exhibitor at CPHI South East Asia 2024 stand P50
About Us

Zhejiang Hisun Pharmaceutical Co., Ltd. located in Taizhou, Zhejiang Province, a coastal city in southeastern China, was founded in 1956. In year 2000, Hisun was listed as a public company in Shanghai A share Stock Exchange. We are the largest antibiotics, anticancer drugs production supplier. We provide diverse products and services. Our research channels cover many indications extensively: like anticancer, cardiovascular, anti-infective, anti-parasitics, immunosuppressant, etc.

  • CN
  • 2015
    On CPHI since
Contact info
Event information
CPHI South East Asia 2024
  • 10 Jul 2024 - 12 Jul 2024
  • Queen Sirikit National Convention Center, Bangkok, Thailand
  • Visit us at stand P50

Products Featured at CPHI South East Asia 2024

  • Orlistat

    Product Orlistat

    OTC weight-reducing drug , DMF available
  • Acarbose

    Product Acarbose

    Antidiabetic Agents, DMF approved, CEP approved
  • Tigecycline

    Product Tigecycline

    Anti-infective API, DMF available
  • Meropenem

    Product Meropenem

    Anti-infective API, DMF available
  • Isepamicin Sulfate

    Product Isepamicin Sulfate

    Anti-infective API, DMF available